American researchers have first successfully completed the study of a vaccine for Ebola. After completing studies in humans, scientists announced that the results, which showed the drug was created to combat the virus are encouraging.
The experts who carried out the 1st test patients reported that a new drug aims to combat the virus that brought fear to the public, many States actually works. The vaccine is not dangerous has no pronounced side effects, additionally, it affects the immune system of the planet, helping it to fight the virus.
It is known that in the research participated citizens who willingly agreed to help researchers. The vaccine, which is the study of the British pharmaceutical giant GlaxoSmithKline (GSK), was introduced in the blood of 20 people in the United States, informs "Bi-bi-si". Over the course of the experiment was observed by many experts, observing the health of animals and their reactions to the product.
For example, scientists from the National institutes of health U.S. Department of the Ministry of health, responsible for the study vaccine - called received the results "encouraging". They stressed that the precedent confirming that none of the participants vaccination is not felt after testing serious side results in itself is positive, together with the fact that all the patients body began to produce antibodies, is considered a breakthrough.
The experiment was as follows and was divided into several parts. Initially, volunteers were divided into 2 groups. 1 received a large dose of the vaccine, and another is small. As a result, it was found that antibodies produced greater the followers of the group that received the high dose. The results of the study were published in the scientific honey the New England journal of Medicine.
It is known that the composition of the vaccine is a genetically altered virus from chimpanzees, which is capable of carrying on its surface a non-infectious protein of Ebola virus. According to the version of doctors, tests of the experimental vaccine will be held in 4 stages. Note that the current study is not yet finished. 2 and 3 stages will be held in West Africa - specifically there will be explained how the vaccine is safe.In addition, to this day not clear how long it can protect the body.
sections: Accidents, World News |